Results 21 to 30 of about 74,557 (274)

Luteal Support and Risk of Ovarian Hyperstimulation in Assisted Reproduction (A Review)

Кубанский научный медицинский вестник, 2020
Background. Gonadotropin-releasing hormone agonist as an ovulation trigger effectively reduces the ovarian hyperstimulation risk in in vitro fertilisation protocols, at the same time requiring an effective luteal phase support in embryo transfer cycles ...
V. A. Krutova, A. A. Baklakova
doaj   +1 more source

Luteal-phase support in assisted reproductive technology: An ongoing challenge

International Journal of Reproductive BioMedicine, 2021
It has been shown that in controlled ovarian hyper stimulation cycles, defective luteal phase is common. There are many protocols for improving pregnancy outcomes in women undergoing fresh and frozen in vitro fertilization cycles.
Saeideh Dashti, Maryam Eftekhar
doaj   +1 more source

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine

F&S Reports, 2023
Gonadotropin-releasing hormone (GnRH) is central to the control of the entire hypothalamic-pituitary-gonadal axis. Manipulation of GnRH, in turn, regulates pituitary response and ovarian hormone production.
Farrah L. Saleh, M.D., Hugh S. Taylor, M.D.   +1 more
doaj   +1 more source

A regulator of G Protein signaling, RGS3, inhibits gonadotropin-releasing hormone (GnRH)-stimulated luteinizing hormone (LH) secretion

BMC Cell Biology, 2001
Background Luteinizing hormone secreted by the anterior pituitary gland regulates gonadal function. Luteinizing hormone secretion is regulated both by alterations in gonadotrope responsiveness to hypothalamic gonadotropin releasing hormone and by ...
Musgrove Lois C, Sellers Jeffrey C, Duck L Wayne, Neill Jimmy D, Kehrl John H   +4 more
doaj   +1 more source

Gonadotropin-releasing hormone agonist contributes to the successful implementation of in vitro fertilization in a patient with cervical endometriosis: a case report

AJOG Global Reports, 2023
This is a case report of a nulliparous young woman who suffered from prolonged menstruation and infertility for 1 year. Magnetic resonance imaging and a transvaginal ultrasound examination revealed cervical endometriosis.
Turui Yang, MD, Jieling Feng, MD, Lu Luo, PhD, Dan Zhang, PhD, Minghui Chen, PhD   +4 more
doaj   +1 more source

Induction of final oocyte maturation in Cyprinidae fish by hypothalamic factors: a review

Veterinární Medicína, 2009
Gonadotropin-releasing hormone in Cyprinidae as in other Vertebrates functions as a brain signal which stimulates the secretion of luteinizing hormone from the pituitary gland. Two forms of gonadotropin-releasing hormone have been identified in cyprinids,
P. Podhorec, J. Kouril
doaj   +1 more source

Gonadotropin-Releasing Hormone Receptors [PDF]

Endocrine Reviews, 2004
GnRH and its analogs are used extensively for the treatment of hormone-dependent diseases and assisted reproductive techniques. They also have potential as novel contraceptives in men and women. A thorough delineation of the molecular mechanisms involved in ligand binding, receptor activation, and intracellular signal transduction is kernel to ...
Colleen A. Flanagan, Zhi-Liang Lu, Stuart Maudsley, Kevin Morgan, Adam J. Pawson, Robert P. Millar, Robert P. Millar   +6 more
openaire   +3 more sources

Cancer Therapy–Related Cardiac Dysfunction in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The risk of cardiac dysfunction for patients with prostate cancer undergoing androgen deprivation therapy (ADT) in the real‐world setting remains unclear.
Dong‐Yi Chen, Cheng‐Hung Lee, Ming‐Lung Tsai, Ming‐Jer Hsieh, Cheng‐Keng Chuang, See‐Tong Pang, Shao‐Wei Chen, Chi‐Nan Tseng, Shang‐Hung Chang, Pao‐Hsien Chu, I‐Chang Hsieh, Victor Chien‐Chia Wu, Wen‐Kuan Huang   +12 more
doaj   +1 more source

Gonadotropin releasing hormone agonists: Expanding vistas

Indian Journal of Endocrinology and Metabolism, 2011
Gonadotropin-releasing hormone (GnRH) agonists are derived from native GnRH by amino acid substitution which yields the agonist resistant to degradation and increases its half-life.
Navneet Magon
doaj   +1 more source

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty

JCRPE, 2021
Objective:A consensus on how to monitor girls with central precocious puberty (CPP) during gonadotropin-releasing hormone agonist (GnRHa) treatment is lacking.
Stefanie Schubert, Amalie H. Hvelplund, Aase Handberg, Søren Hagstroem, Tina Lund Leunbach   +4 more
doaj   +1 more source